Skip to content
Screener

Net Income at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
-$15.05M-226%
Viatris logo
ViatrisVTRS
-$118.8M-2,483%
PTH
Pelthos TherapeuticsPTHS
-$10.24M-420%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$8.75M-88.3%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$8.65M-24.4%
Opko Health logo
Opko HealthOPK
-$8.42M+94.3%

Other financials

Income statement

See full
Revenue$8.6M+72.1%
Gross profit$4.2M+15.1%
Operating income-$32.2M-15.3%
EPS (diluted)-$6.28-178%

Balance sheet

See full
Cash & equivalents$3.4M-42.2%
Total debt$95.4M+130%
Total equity-$249.2M-17.8%
Total assets$293.6M+272%

Cash flow

See full
Operating cash flow-$1.1M-118%
CapEx$33.3K
Free cash flow$920.8K-63.7%

Valuation

See full
Market cap$39.46M-68.5%
Enterprise value$131.46M-19.4%
P/S1.2×-1.7×

Profitability

See full
Gross margin59.7%-12.3pp
Operating margin-1,034.4%-1,313pp
Net margin-1,162.4%-1,359pp
FCF margin12.2%

Returns & leverage

See full
Return on equity170.9%
Debt / equity0.3×
Current ratio0.1×0.0×

Where this comes from

Reported directly by Scilex Holding Company in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: Scilex Holding Company’s 10-Q, filed May 20, 2026.

Filed
May 20, 2026, 5:22 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-232857
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Realized loss on securities3,071
Total other (income) expense, net13,481(1,818)
Loss before income taxes(45,650)(26,080)
Net loss(45,650)(26,080)
Net loss attributable to noncontrolling interests(2,380)
Net loss attributable to common stockholders$(43,270)$(26,080)
Loss per share attributable to common stockholders — basic & diluted$(6.28)$(2.26)
Weighted average number of shares during the period — basic & diluted6,89111,565

Item 1. Financial Statements

FAQ

What is Scilex Holding Company's net income?
Scilex Holding Company (SCLX) reported net income of -$45.65M in Q1 2026.
How has Scilex Holding Company's net income changed year-over-year?
Scilex Holding Company's net income decreased by 75.0% year-over-year, from -$26.08M to -$45.65M.
What is the long-term trend for Scilex Holding Company's net income?
Over 4 years (2021 to 2025), Scilex Holding Company's net income has grown at a 43.4% compound annual growth rate (CAGR), from -$88.42M to -$374.05M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Ask your AI about Scilex Holding Company's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude